EUROECHO 2007 Lisbon, Portugal, December 5 – 8, 2007 Carotid scanning: an extension of the routine echocardiography study? Damiano Baldassarre Enrica Grossi.

Slides:



Advertisements
Similar presentations
THE ACTION TO CONTROL CARDIOVASCULAR RISK IN DIABETES STUDY (ACCORD)
Advertisements

Tasneem Z Naqvi, MD, FRCP (UK), RVT, MMM Director Non-invasive Cardiology and Echocardiography Professor of Medicine and Clinical Scholar Keck School of.
New concepts and guidelines in the management of LDL-c and CV Risk: Need for early intervention Prof. Ulf Landmesser University Hospital Zürich Switzerland.
R Dhangana, TP Murphy, MJ Pencina, MB Ristuccia, JV Cerezo, D Tsai Prevalence of Low Ankle-Brachial Index, Elevated Plasma Fibrinogen and CRP Among Those.
CVD prevention & management: a new approach for primary care Rod Jackson School of Population Health University of Auckland New Zealand.
Absolute cardiovascular disease risk Assessment and Early Intervention Dr Michael Tam Lecturer in Primary Care
1 Journal Club Alcohol, Other Drugs, and Health: Current Evidence November–December 2010.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence May-June 2008.
Uncontrolled Hypertension, Systolic and Diastolic Blood Pressure and Development of Symptomatic Peripheral Arterial Disease in the Women’s Health Study.
Long-term predictive value of assessment of coronary atherosclerosis by contrast- enhanced coronary computed tomography angiography: meta- analysis and.
Chapter 4 Cardiovascular disease
Overly concerning and falsely reassuring?? FRAMINGHAM RISK FACTORS IN THE ED.
Surrogate Measures of Atherosclerosis and Implications for Evaluating Cardiovascular Risk Nathan D. Wong, Ph.D., F.A.C.C. Associate Professor and Director.
Only You Can Prevent CVD Matthew Johnson, MD. What can we do to prevent CVD?
Carotid Intima-Media Thickness (CIMT): A Reproducibility Study Mindy Columbus, Brian Wagner, Emma Barinas-Mitchell Department of Epidemiology, University.
C-REACTIVE PROTEIN, FIBRINOGEN, AND CARDIOVASCULAR DISEASE PREDICTION By Patrick Whitledge PA-S2 South University Physician Assistant Program.
{ A Novel Tool for Cardiovascular Risk Screening in the Ambulatory Setting Guideline-Based CPRS Dialog Adam Simons MD.
ASTEROID A Study To evaluate the Effect of Rosuvastatin On Intravascular ultrasound- Derived coronary atheroma burden.
Funded by the EC, FP 6, Contract No (FOOD) Blood lipids among young children in Europe: results from the European IDEFICS study Stefaan De Henauw.
COURAGE: Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation Purpose To compare the efficacy of optimal medical therapy (OMT)
Results of Monotherapy in ALLHAT: On-treatment Analyses ALLHAT Outcomes for participants who received no step-up drugs.
SERUM VISFATIN CONCENTRATION IS ASSOCIATED WITH AN ATHEROGENIC METABOLIC PROFILE T.D. Filippatos 1, A. Liontos 1, F. Barkas 1, E. Klouras 1, V. Tsimihodimos.
AN ASSESSMENT OF THE PRIMARY PREVENTION CONTROL PROGRAM OF PHC PREVENTIVE CARDIOLOGY CLINIC AMONG PATIENTS AT RISK FOR CVD: A Retrospective Cohort Study.
NON-INVASIVE VASCULAR IMAGING TECHNIQUES
Multiple risk factors raise ischaemic stroke risk comparable to AF in the elderly: A large Chinese insurance analysis from 425,600 Chinese individuals.
ASSIGN Paul Ryan, Clinical Director, North Glasgow CHCP.
10 Points to Remember on the Assessment of Cardiovascular RiskAssessment of Cardiovascular Risk Summary Prepared by Melvyn Rubenfire, MD.
Management of Elevated Cholesterol in the Primary Prevention Group of Adult Japanese (MEGA) Trial MEGA Trial Presented at The American Heart Association.
Clinical Trial Results. org Long-Term Prognosis Associated with Coronary Calcification Matthew J. Budoff, MD, Leslee J. Shaw, PhD, Sandy T. Liu, Steven.
Coagulation / Fibrinolytic Factors in PCOS. The Alternative Hypothesis : Conversely, PCOS women may be protected from later life onset of CHD by the altered.
Lower the better; the case for glucose Professor Taner DAMCI Istanbul University Cerrahpaşa Medical School, TURKEY.
Calculated LDL by Age Cases vs. Controls Figure 1.
Introduction Lipoprotein(a) [Lp(a)]
1 INTIMA MEDIA THICKNESS AND ATHEROSCLEROSIS Michele CAZAUBON, MD, PhD American Hospital of Paris ( France)
Monocyte damaged endothelium macrophage foam cell lipid thrombocytes plaque oxidative stress smooth muscle cells 4 5 Gaviraghi et al., 1998 Lacidipine:
SPARCL Stroke Prevention by Aggressive Reduction in Cholesterol Levels trial.
Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol 2 ARBITER-2 Trial Presented at The American Heart Association Scientific.
Predictive Value of Coronary Calcium Scoring Matthew Budoff, MD, FACC, FAHA Associate Professor of Medicine UCLA School of Medicine Director, Cardiac CT.
Hypothesis Evaluated in these Papers
Describing the risk of an event and identifying risk factors Caroline Sabin Professor of Medical Statistics and Epidemiology, Research Department of Infection.
Section III. Assessment of Overall Cardiovascular Risk in Hypertensive Patients 2015 Canadian Hypertension Education Program Recommendations.
Identifying Persons in Need of Weight-loss Treatment: Evaluation of Potential Treatment Algorithms Caitlin Mason School of Physical and Health Education.
VBWG Growth in heart disease, 2000–2050 Deaths Population Foot DK et al. J Am Coll Cardiol. 2000;35:
Clinical Trial Results. org METEOR Trial Presented at the American College of Cardiology Annual Scientific Session March, 2007 Presented by Dr. John R.
Probability and odds Suppose we a frequency distribution for the variable “TB status” The probability of an individual having TB is frequencyRelative.
High Coronary Calcification Scores Predict Mortality in Pre-Dialysis CKD Patients Reference: Haas MH. The risk of death in patients with a high coronary.
DIABETES INSTITUTE JOURNAL CLUB CARINA SIGNORI, D.O., M.P.H. DECEMBER 15, 2011 Atherothrombosis intervention in metabolic syndrome with low HDL/High Triglycerides:
Peripheral Artery Disease in Orthopaedic Patients with Asymptomatic Popliteal Artery Calcification on Plain X-ray Adam Podet, MS; Julia Volaufova, phD,;
TAHAR EL KANDOUSSI, SARA ECHERKI, NAWAL DOGHMI, MOHAMED CHERTI. SEcurite de l’Echocardiographie de stress : plutôt l’effort. Cardiology B Department, Ibn.
The JUPITER Trial Reference Ridker PM. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med. 2008;359:2195–2207.
Case 1: Elevated LDL-C in a Young Adult. Page 2 of 10 *DALY; disability-adjusted life years Routine checkup:  Age:33 years  Sex: male  Status: Except.
Date of download: 6/22/2016 Copyright © The American College of Cardiology. All rights reserved. From: Assessment of Coronary Plaque Progression in Coronary.
Atherosclerosis quantification by ultrasound Henrik Sillesen MD, DMSc Chairman & professor Dept. Vascular Surgery, Rigshospitalet Univ. of Copenhagen,
Alcohol, Other Drugs, and Health: Current Evidence July–August 2017
Background/Objective
1 Figure 1: Patient Setup and Sample VENDYS DTM Report
Coagulation/Fibrinolytic Factors in PCOS
Phenotype vs. Genotype: Defining Severe Familial Hypercholesterolemia
PS Sever, PM Rothwell, SC Howard, JE Dobson, B Dahlöf,
Intensive Observation Unit Careggi University Hospital, Firenze Italy
Systolic Blood Pressure Intervention Trial (SPRINT)
Type 2 diabetes: Overlap of clinical conditions
Section 7: Aggressive vs moderate approach to lipid lowering
Insights from the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT)
Giuseppe Biondi Zoccai, MD
Separate and combined associations of body-mass index and abdominal adiposity with cardiovascular disease: collaborative analysis of 58 prospective studies 
An example of the Lancet
Correlation between endothelial function and hypertension
Goals & Guidelines A summary of international guidelines for CHD
Simvastatin in Patients With Prior Cerebrovascular Disease: HPS
Presentation transcript:

EUROECHO 2007 Lisbon, Portugal, December 5 – 8, 2007 Carotid scanning: an extension of the routine echocardiography study? Damiano Baldassarre Enrica Grossi Paoletti Centre Department of Pharmacological Sciences, University of Milan and Cardiologico Monzino Centre IRCCS INTIMA-MEDIA THICKNESS AND ATHEROSCLEROSIS

INTIMA MEDIA THICKNESS (IMT) Near wall Far wall COMMON CAROTID BULB ICA ECA Non-invasive marker of early arterial wall alteration. Easily assessed by B-mode ultrasound. IMT

Ultrasound Histology Echogenic lines { { Lumen Adventitia Intima Media Thickness (IMT) Media Adventitia interface Blood intima interface Intimal plus media thickness of the arterial wall: a direct measurement with ultrasound imaging. Pignoli P, Tremoli E, Poli A, Oreste P, Paoletti R. Circulation 1986;74:

Methodology for IMT measurement (widely used in clinical research) PUBMED KEYWORDS: “Carotid IMT” OR "intima media thickness" OR "intimal medial thickness" OR "intima-media thickness" OR "intimal plus medial complex“. Pubmed limits: Humans and English Year of publication N° of studies published per year (as an index of interest of the scientific community for this methodology) starting from 1986, when the study of Pignoli was published the interest increases exponentially with the time (about a 1000 papers published in the last 3 years )

What have we learned from this big amount of information?

CAROTID IMT is associated: with the same vascular risk factors known to affect atherosclerosis at coronary level with the extent of coronary disease as assessed by angiography with the presence of clinical signs of coronary disease (i.e. AMI, angina etc.) with the incidence of previous vascular events IMT is now widely used in clinical trials as a marker of atherosclerosis to evaluate the effects of pharmacological agents

Despite this big amount of information, little is known about the usefulness of IMT as an additive marker of cardiovascular risk to be used in clinical practice on an individual basis.

Carotid IMT, measured with an electronic caliper (a method feasible in routine clinical practice) provides suitable information to associate carotid IMT –with atherosclerosis in other vascular districts –with the risk profile of the patient.

In a first series of cross-sectional studies, mainly performed in patients attending our Lipid Clinic, we have shown that carotid IMT, as measured in clinical practice, correlates well with coronary VRFs CAROTID ARTERY INTIMA-MEDIA THICKNESS MEASURED BY ULTRASONOGRAPHY IN NORMAL CLINICAL PRACTICE CORRELATES WELL WITH ATHEROSCLEROSIS RISK FACTORS. Baldassarre D, Amato M, Bondioli A, Sirtori CR, Tremoli E. Stroke 2000;31: INCREASED CAROTID ARTERY INTIMA-MEDIA THICKNESS IN SUBJECTS WITH PRIMARY HYPOALPHALIPOPROTEINEMIA. Baldassarre D, Amato M, Pustina L, Tremoli E, Sirtori CR, Calabresi L, Franceschini G. Arterioscler, Thromb Vasc Biol 2002;22: CORRELATION OF PARENTS’ LONGEVITY WITH CAROTID INTIMA-MEDIA THICKNESS IN PATIENTS ATTENDING A LIPID CLINIC. Baldassarre D, Amato M, Veglia F, Pustina L, Castelnuovo S, Sirtori CR, and Tremoli E. Atherosclerosis 2005;179:

Characteristics of subjects with and without Coronary Heart Disease (CHD) With CHD (n=133) Without CHD (n=266) p Men (%)76 match Age (years)57.5 match Smokers (%) ns BMI (Kg/m2 ) ns SBP (mmHg) ns DBP (mmHg) ns TC (mg/dl) match LDL-C (mg/dl) ns HDL-C (mg/dl) ns TG (mg/dl) ns Lp(a) (mg/dl) ns Blood glucose (mg/dl) ns Uric acid (mg/dl) ns Max-IMT (mm) MM-IMT (mm) Baldassarre et al., Stroke 2000;31:

even when measured in the routine clinical practice, carotid IMT is a suitable marker: These results support very well the concept that: to investigate the effect of vascular risk factors to identify groups of patients with and without a history of vascular events they do not provide any information concerning the potential role of IMT as a test for predictive purposes on individual basis

Before a new test can be used for predictive purposes Essential to establish its performance in the recognition of those individuals who PREVENTIVE MEDICINE effectively had experienced the target end point. had not

Thus, we have performed a study aimed at investigating on an individual basis whether IMT measurements can be added to, or used instead of, vascular risk factors in the recognition of patients with and without a history of vascular events

RECOGNITION OF PATIENTS WITH AND WITHOUT VASCULAR EVENTS BY ARTIFICIAL NEURAL NETWORK ANALYSES Combining some ultrasonic variables with a set of clinical variables, it was possible to reach an accuracy of prediction of about 92%, with 95% of correct classification of patients with a history of vascular events 91% of correct classification of those without Patients without events (specificity) 91% Patients with events (sensitivity) 95% Weighted Mean (Prediction accuracy) 92% Thus, also the results of this study supported a potential role of carotid IMT to be used for predictive purposes Baldassarre et al., Ann Med. 2004;36(8):

1.Is there a direct correlation between carotid and coronary atherosclerosis? Before trying to use carotid IMT for predictive purposes three further questions had to be answered: 2.In what kind of patients IMT measurement may actually have the highest clinical usefulness? 3.what threshold value has to be adopted to obtain the maximal IMT predictive capacity?

1.Is there a direct correlation between carotid and coronary disease? 2.In what kind of patients IMT measurement may actually have the highest clinical usefulness? 3.what threshold value has to be adopted to obtain the maximal IMT predictive capacity? Before trying to use carotid IMT for predictive purposes three questions had to be answered:

AUTOPSY STUDIES Significant correlation between carotid and coronary atherosclerosis (correlation coefficient = ) CAROTID AND CORONARY ATHEROSCLEROSIS Young et al., Am J Cardiol 1960;6: Holme et al. Arteriosclerosis 1981 Mitchell et al. BMJ 1962;5288: CC Bif ICA ECA weaker correlations (r ≈ 0.3) VS (B-mode Ultrasound)(Quantitative angiography) Carotid Atherosclerosis Coronary Atherosclerosis IN VIVO STUDIES Adams Circulation Balbarini Angiology Holaj Can J Cardiovasc 2003

This lower correlation was just due to methodological problems HYPOTHESIS External carotid ultrasound (ECU) is focused on arterial wall Quantitative coronary angiography (QCA) provides information on arterial lumen diameter

INTRAVASCULAR ULTRASOUND (IVUS) The miniaturisation of high-frequency intravascular ultrasound transducers has allowed the direct examination, in living humans, of the thickening of vessel walls of coronary arteries

AIM OF THE STUDY To evaluate whether a correlation closer to the one obtained in autopsy studies can be obtained by measuring carotid and coronary atherosclerosis by using more homogeneous arterial wall parameters, i.e. IMT, in both vascular districts

APPROACH Carotid wall B-Mode ultrasound Coronary lumen Classical approach VS Angiography Coronary wall More homogeneous parameters from both vascular districts VS Intravascular ultrasound

Correlation coefficients between Carotid and Coronary atherosclerosis Autopsy Studies (mean of 3 studies) Correlation coefficient (r) PRESENT STUDY DATA REPORTED IN LITERATURE Carotid IMT Vs Angiography (mean of 6 studies) %DS Carotid IMT Vs IVUS (Present study) C-IMT Mean C-IMT Max Thus, carotid IMT correlates very well with coronary atherosclerosis Correlation coefficients between carotid IMT and coronary lumen were much lower than those observed in autopsy studies those obtained evaluating IMT in both arterial districts were much higher and reach values very similar to the ones observed in studies post- mortem

1.Is there a direct correlation between carotid and coronary disease? 2.In what kind of patients IMT measurement may actually have the highest clinical usefulness? 3.what threshold value has to be adopted to obtain the maximal IMT predictive capacity? Before trying to use carotid IMT for predictive purposes three questions had to be answered:

Patients at high risk (e.g. those with a Framingham Risk Score >20%) are already qualified for aggressive treatment Is the population with FRS≥20% (high risk) a good target for IMT measurements? Thus, in this kind of patients, no further risk stratification tools are needed.

Patients at intermediate-risk (FRS: 10-20%) represent for many clinicians a gray decision area In fact, although these patients do not currently qualify for aggressive treatment, epidemiological and clinical evidences show that cardiac events occur in many of these individuals The number of patients at intermediate-risk is high (for instance, they constitute 40% of the US population) Thus, tools to further stratify the risk in patients at intermediate- risk are actually needed

1.Is there a direct correlation between carotid and coronary disease? 2.In what kind of patients IMT measurement may actually have the highest clinical usefulness? 3.what threshold value has to be adopted to obtain the maximal IMT predictive capacity? Before trying to use carotid IMT for predictive purposes three questions had to be answered:

2,381,881,380,880,38 Frequency MEAN MAX IMT IMT ≥ 1 mm LowHigh Epidemiologic data currently available indicate that a value of IMT equal or greater than 1 mm at any age is associated with a significantly increased risk of myocardial infarction or cerebrovascular disease. Folsom et al. Diabetes Care 2003;26: Chambless et al. Clin Epidemiol 2003;56:880. Salonen et al. Arterioscler Thromb 1991;11: Chambless et al. Am J Epidemiol 1997;146:483. Risk of CAD and CVD GENERAL POPULATION

A longitudinal observational study aimed at investigating whether the measurement, in clinical practice, of carotid Max-IMT could be combined with the FRS to improve the predictability of cardiovascular events in patients who are at low or intermediate risk AIM OF THE STUDY Baldassarre et al., Atherosclerosis 2006 May 6 [Epub ahed of print]

The addition to the FRS of the “plaque status”, expressed in terms of presence or absence of a Max-IMT value ≥1 mm (or even ≥ 1.3 mm), did not significantly improve the predictive power of the FRS. Thus, can we say that IMT has not predictive capacity? NO !

Age and sex known to have a major impact on IMT measurements have not been taken into account. Baldassarre et al., STROKE 2000;31: WomenMen Age adjusted Max-IMT (mm) P< Effect of gender on carotid IMT r =0.43 p< Age (years) Max-IMT (mm) Effect of age on carotid IMT

MEN DECADES OF AGE (years) Max-IMT (mm) 90 th 80 th 70 th 60 th 50 th 40 th 30 th 20 th 10 th WOMEN DECADES OF AGE (years) Max-IMT (mm) 90 th 80 th 70 th 60 th 50 th 40 th 30 th 20 th 10 th Deciles of Max-IMT distribution Deciles of Max-IMT distribution in men and women calculated in a group of about 2000 Italian dyslipidemic patients, plotted for 10- years age intervals. Baldassarre et al., Atherosclerosis. 2007;191(2):

DECADES OF AGE (years) Max-IMT (mm) 90 th 80 th 70 th 60 th 50 th 40 th 30 th 20 th 10 th DECADES OF AGE (years) Max-IMT (mm) 90 th 80 th 70 th 60 th 50 th 40 th 30 th 20 th 10 th Deciles of Max-IMT distribution In selected populations affected by major risk factors like patients with dyslipidemia, hypertension, or diabetes, an IMT greater than 1 mm is present in almost every patient above 50 years of age MENWOMEN Baldassarre et al., Atherosclerosis. 2007;191(2):

DECADES OF AGE (years) Max-IMT (mm) 90 th 80 th 70 th 60 th 50 th 40 th 30 th 20 th 10 th DECADES OF AGE (years) Max-IMT (mm) 90 th 80 th 70 th 60 th 50 th 40 th 30 th 20 th 10 th Deciles of Max-IMT distribution In addition, if age and sex are not taken into account, each patient with an IMT ≥1 mm is classified as having the same risk either if man or women, and either if young or old; MENWOMEN Baldassarre et al., Atherosclerosis. 2007;191(2):

DECADES OF AGE (years) Max-IMT (mm) 90 th 80 th 70 th 60 th 50 th 40 th 30 th 20 th 10 th DECADES OF AGE (years) Max-IMT (mm) 90 th 80 th 70 th 60 th 50 th 40 th 30 th 20 th 10 th Deciles of Max-IMT distribution In addition, if age and sex are not taken into account, each patient with an IMT ≥1 mm is classified as having the same risk either if man or women and either if young or old; MENWOMEN but, if we consider for example an IMT value of 1.3 mm, this may be the highest value within the IMT distribution of young patients but even the lowest one when the IMT distribution of patients older 50 are considered Baldassarre et al., Atherosclerosis. 2007;191(2):

DECADES OF AGE (years) Max-IMT (mm) 90 th 80 th 70 th 60 th 50 th 40 th 30 th 20 th 10 th DECADES OF AGE (years) Max-IMT (mm) 90 th 80 th 70 th 60 th 50 th 40 th 30 th 20 th 10 th Deciles of Max-IMT distribution In addition, by using this approach, each patient with an IMT value greater than 1 mm is classified as having the same risk either if he has an IMT of 1.1 mm or if he has an IMT of 2.5 mm or greater: this is out of any biological plausibility. MENWOMEN Baldassarre et al., Atherosclerosis. 2007;191(2):

MEN DECADES OF AGE (years) Max-IMT (mm) 90 th 80 th 70 th 60 th 50 th 40 th 30 th 20 th 10 th WOMEN DECADES OF AGE (years) Max-IMT (mm) 90 th 80 th 70 th 60 th 50 th 40 th 30 th 20 th 10 th Deciles of Max-IMT distribution To overcome this problem in our study the “best threshold values” (BTVs), above which to consider Max-IMT as abnormally high, were calculated for each 10-years age interval in men and women. Baldassarre et al., Atherosclerosis. 2007;191(2):

MEN DECADES OF AGE (years) Max-IMT (mm) 90 th 80 th 70 th 60 th 50 th 40 th 30 th 20 th 10 th WOMEN DECADES OF AGE (years) Max-IMT (mm) 90 th 80 th 70 th 60 th 50 th 40 th 30 th 20 th 10 th Deciles of Max-IMT distribution To overcome this problem in our study the “best threshold values” (BTVs), above which to consider Max-IMT as abnormally high, were calculated for each 10-years age interval in men and women. These were found to be the 60 th and 80 th percentiles of Max-IMT distribution for men and women, respectively, for each decade of age. Baldassarre et al., Atherosclerosis. 2007;191(2): By using these new IMT threshold values the results of the analyses completely changed

a FRS above 10% was associated with an HR of 2.60; p = 0.03 (95% CI ) Baldassarre et al., Atherosclerosis. 2007;191(2): Repeating the Cox analysis, using these BTVs as stratification tools: FRS Max-IMT a Max-IMT above BTV gave a HR of 2.42; p = 0.04 (95% CI ) independent predictors of new cardiovascular events.

Max-IMT < BTV Max-IMT ≥ BTV FRS < 10% 10<FRS<20% Max-IMT best threshold value (BTV): men = 60 th percentile women = 80 th percentile Stratifying the study population according to the presence of a FRS above or below 10% and Max-IMT above or below BTV Values are adjusted for pharmacological treatments Hazard ratio Baldassarre et al., Atherosclerosis. 2007;191(2):

Max-IMT < BTV Max-IMT ≥ BTV FRS < 10% 10<FRS<20% Max-IMT best threshold value (BTV): men = 60 th percentile women = 80 th percentile Values are adjusted for pharmacological treatments P< P< (p=0.01) Hazard ratio Baldassarre et al., Atherosclerosis. 2007;191(2): the strength of the associations between Max-IMT and outcome was at least as strong as the associations seen with FRS the concomitant presence of FRS ≥10% and Max-IMT above the BTV yielded a marked increase in the HR. Stratifying the study population according to the presence of a FRS above or below 10% and Max-IMT above or below BTV

Log Hazard Ratio Values are adjusted for pharmacological treatments Max-IMT best threshold value (BTV): men = 60 th percentile women = 80 th percentile p= Baldassarre et al., Atherosclerosis. 2007;191(2): Max-MT<BTV Max-MT≥BTV Intermediate risk 10≤FRS<20% Low risk FRS<10% High risk 20<FRS<30% HR FOR HAVING A NEW CARDIOVASCULAR EVENT IN LOW, INTERMEDIATE AND HIGH RISK GROUPS In addition, compared to low-risk patients

Max-MT< BTVMax-MT ≥ BTVMax-MT< BTVMax-MT ≥ BTV Incidence of cardiovascular events (%) Low risk patients (FRS<10%) Intermediate risk patients (10%<FRS<20%) Threshold for drug therapy Predicted incidence by the Framingham Risk Score Observed incidence incidence of new cardiovascular events predicted on the basis of FRS vs. incidence actually observed (estimated by the Kaplan-Meyer method) Baldassarre et al., Atherosclerosis. 2007;191(2):

Predicted incidence by the Framingham Risk Score Incidence of cardiovascular events (%) Threshold for drug therapy Observed incidence Max-MT< BTVMax-MT ≥ BTV Low risk patients (FRS<10%) incidence of new cardiovascular events predicted on the basis of FRS vs. actually observed incidence (estimated by the Kaplan-Meyer method) Max-MT< BTVMax-MT ≥ BTV Intermediate risk patients (10%<FRS<20%) Baldassarre et al., Atherosclerosis. 2007;191(2):

Predicted incidence by the Framingham Risk Score Incidence of cardiovascular events (%) Low risk patients (FRS<10%) Threshold for drug therapy Observed incidence incidence of new cardiovascular events predicted on the basis of FRS vs. actually observed incidence (estimated by the Kaplan-Meyer method) Max-MT ≥ BTV Intermediate risk patients (10%<FRS<20%) Ratio = 3.11 Baldassarre et al., Atherosclerosis. 2007;191(2): On the basis of the two last histograms it can be calculated that the “actually observed incidence of new cardiovascular events” can be better predicted by FRS if this is multiplied for 3.11.

IMT as predictor of vascular events

O’Leary et al. New Eng J Med 1999 One American study provides convincing evidences that carotid artery IMT is a good predictor of new vascular events. about the 95% of the subjects with an IMT classifiable in the first quintile were free of vascular events. In contrast, the percentage of subjects free of vascular events in the group with the highest quintile of IMT was less than 75% 4500 patients 65 years or older Follow up: about 7 years Thus suggesting that carotid IMT may be effectively considered as a good marker of evolutive atherosclerotic disease.

THE IMPROVE STUDY Carotid Intima Media Thickness (IMT) and IMT-Progression as Predictors of Vascular Events in a High Risk European Population

The IMPROVE Study is a multicenter, longitudinal, observational study carried out in an Pan-European population of 3732 patients at high risk of cardiovascular disease for the presence of at least three vascular risk factors. DESIGN Vascular risk factors: Male or Female at least 5 years after menopause Hypercholesterolemia Hypertriglyceridemia Hypo-alpha-lipoproteinemia Hypertension Diabetes Smoking habits Family history of cardiovascular diseases SWEDEN n=533 FINLAND n=1050 (2 clinical centers) FRANCE n=501 THE NETHERLANDs n=553 ITALY n=1095 (2 clinical centers)

OBJECTIVE Cross-sectional carotid IMT To evaluate the association between the rate of subsequent vascular events Carotid IMT-progression within 15 months

Baseline carotid IMT Mean-Max as predictor of new cardiovascular events 1 st quintile 2 nd quintile 3 rd quintile 4 th quintile 5 th quintile % event free follow-up (years) 1.00 IMT Mean-Max < 1.04 > Thus, also in an European population carotid IMT is a very good predictor of new vascular events

Since carotid IMT: correlates well with atherosclerosis risk factors correlates well with coronary atherosclerosis can be used in clinical practice to enhance the predictability of cardiovascular events in patients who fall into the intermediate-risk category is a very good predictor of new vascular events Summary

Carotid IMT is an excellent marker of carotid and even coronary atherosclerosis CONCLUSION